Related Experiment Video
Updated: Jun 7, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
A synbiotic mixture for the management of infantile colic: A randomized trial
Hanne Delcourt1, Koen Huysentruyt1, Yvan Vandenplas2
1Vrije Universiteit Brussel (VUB), UZ Brussels, KidZ Health Castle, Laarbeeklaan 101, 1090, Brussels, Belgium.
Insights
A synbiotic significantly improved infant colic symptoms and caregiver quality of life within one week. This treatment demonstrated efficacy regardless of infant feeding type, offering rapid relief for colicky infants.
Area of Science:
- Pediatrics
- Gastroenterology
- Microbiome Research
Background:
- Infant colic is characterized by prolonged, inconsolable crying in infants.
- While some probiotics show efficacy in breastfed infants, evidence for synbiotics is less established.
- Caregiver quality of life is significantly impacted by infant colic.
Purpose of the Study:
- To evaluate the efficacy of a specific synbiotic (Bactecal D Liquid) in managing infant colic.
- To assess the impact of the synbiotic on caregiver quality of life and infant crying symptoms.
- To compare the effectiveness of once-daily versus twice-daily dosing of the synbiotic.
Main Methods:
- A randomized trial involving 68 infants diagnosed with probable infant colic.
- Infants received either one or two daily doses of the synbiotic for 28 days.
- Primary outcome: caregiver quality of life (Likert scale); Secondary outcomes: crying episodes, crying time, gassiness, and physical distress indicators.
Main Results:
- Caregiver quality of life scores significantly improved from baseline to day 28 (p < 0.001).
- Significant improvements in quality of life were observed within one week of intervention.
- Infant crying episodes, crying time, gassiness, and "balling of fists" significantly decreased by day 28 (p < 0.001).
- No significant difference in efficacy was found between once-daily and twice-daily dosing.
Conclusions:
- The tested synbiotic is effective in managing infant colic.
- Rapid symptom improvement and enhanced caregiver quality of life were observed within seven days.
- The synbiotic's benefits were independent of infant feeding method (breastfeeding, formula, or mixed).
Abstract:
Infant colic is defined as a recurrent and prolonged period of fussing, crying and/or irritability that cannot be prevented or resolved by caregivers. The aim of this study is to evaluate the efficacy of a synbiotic (Bactecal D Liquid) in infants consulting a primary health care professional for inconsolable crying. A randomized trial was conducted in 68 infants diagnosed by the consulted primary health care professional as "probably suffering from infant colic". Patients were randomized into two groups and given the synbiotic once (group 1) or twice (group 2) a day for 28 days. Quality of life (QoL) of the caregivers, evaluated with a Likert scale, was the primary outcome. Secondary outcomes included the total number of crying episodes, total crying time, gassiness and "balling of the fists". The median (Q1;Q3) QoL scores were significantly (p < 0.001) higher on day 28 than at baseline: 6 (5;7) vs 2 (1;3). At baseline, there was no significant difference (p = 0.527) in QoL between both groups. The improvement in QoL was already significant after one week of intervention for both groups. The median number of crying episodes, overall crying time, gassiness and "balling of fists" were significantly lower on day 28 compared to baseline (p < 0.001).
Conclusion:
The synbiotic tested was shown to be efficacious in the management of infant colic. A significant improvement was observed after 7 days of intervention, which is much earlier than the expected decrease related to the natural evolution of infant colic.
What Is Known:
• Some probiotic strains are reported to be effective in the management of infants presenting with colic, if breastfed.
What Is New:
• The synbiotic studied improved quality of life of caregivers of infants presenting infant colic. • Two doses of the synbiotic were not more effective than one dose. • The improved occurred within one week. • The improvement was independent of feeding (breastfeeding, formula feeding or mixed feeding).
More Related Videos
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

